Growth Metrics

Milestone Scientific (MLSS) Current Deferred Revenue (2016 - 2021)

Milestone Scientific (MLSS) has disclosed Current Deferred Revenue for 7 consecutive years, with $407050.0 as the latest value for Q3 2021.

  • Quarterly Current Deferred Revenue rose 19.55% to $407050.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $407050.0 through Sep 2021, up 19.55% year-over-year, with the annual reading at $242589.0 for FY2020, 28.75% down from the prior year.
  • Current Deferred Revenue hit $407050.0 in Q3 2021 for Milestone Scientific, up from $337145.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $2.8 million in Q2 2018 to a low of $241288.0 in Q1 2021.
  • Historically, Current Deferred Revenue has averaged $595384.8 across 5 years, with a median of $372700.0 in 2019.
  • Biggest five-year swings in Current Deferred Revenue: surged 690.68% in 2018 and later crashed 86.77% in 2019.
  • Year by year, Current Deferred Revenue stood at $1.7 million in 2017, then tumbled by 75.55% to $421800.0 in 2018, then dropped by 19.28% to $340476.0 in 2019, then fell by 28.75% to $242589.0 in 2020, then skyrocketed by 67.79% to $407050.0 in 2021.
  • Business Quant data shows Current Deferred Revenue for MLSS at $407050.0 in Q3 2021, $337145.0 in Q2 2021, and $241288.0 in Q1 2021.